Hualan Biological shareholders approve half-year profit distribution plan

Hualan Biological Engineering Incorporated Company held its second extraordinary general meeting of shareholders for 2025 on September 22, 2025. Shareholders approved the "Proposal on Profit Distribution for the First Half of 2025." The meeting, held both physically and online, saw 1,176 shareholders and proxies representing 902,217,804 shares, or 49.3701% of the total voting shares, in attendance.

The core resolution, concerning the 2025 half-year profit distribution, passed with a significant majority. A total of 899,267,691 shares voted in favor, representing 99.6730% of the effective voting shares present. There were 2,860,813 shares (0.3171%) against the proposal, and 89,300 shares (0.0099%) abstained.

For small and medium investors, support was also strong, with 57,147,652 shares (95.0911%) voting in favor, 2,860,813 shares (4.7603%) against, and 89,300 shares (0.1486%) abstaining. The company confirmed that all procedures for the meeting and the resolution's adoption were in compliance with relevant laws and regulations, as validated by Anhui Chengyi Law Firm.